Axol Bioscience cardiomyocytes are derived from human iPSCs.
Human iPSC-derived Atrial Cardiomyocytes (1 million cells per vial)
How much do I need?
Click to use our product calculator.
Human iPSC-Derived Atrial Cardiomyocytes (Male)
From: $494.00
Product code:
Description
Human iPSC-Derived Atrial Cardiomyocytes (Male)
Axol iPSC-Derived Atrial Cardiomyocytes express atrial specific markers atrial myosin light chain 2 (MLC2a) and atrial natriuretic peptide (ANP). Atrial cardiomyocytes are key for the study of atrial fibrillation such as irregular heart rate making them excellent for disease modelling.
Our iPSC-derived Atrial Cardiomyocytes have been derived from the same 74 year old male donor as our highly-validated iPSC-Derived Ventricular Cardiomyocytes. Axol iPSC-derived cardiomyocytes and fully-defined, serum-free Cardiomyocyte Maintenance Medium offers researchers a complete portfolio of complementary cell types and culture reagents for disease modelling and cardiotoxicity testing.
Product Specification
| Starting material | Fibroblasts |
| Donor gender | Male |
| Donor age at sampling | 74 yrs |
| Reprogramming method | Episomal vector |
| Induction method | Fully defined medium |
| Size | 1 million cells |
| Growth properties | Adherent |
| Disease information | Healthy |
| Shipping conditions | Dry ice |
| Storage conditions | vapour phase nitrogen |
